The effects of these polymorphisms suggested a close relationship between PI3K, PTEN, Mdm2 and p53 and the efficacy of radio-chemotherapy treatment of adenocarcinoma and the survival time of patients. The gene discussed is PIK3CG; the disease is adenocarcinoma.